Royalty Pharma plc (RPRX)
NASDAQ·Healthcare·Biotechnology
$49.81
+0.60%
Mkt Cap $21.20B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (12 analysts)
$51.25
Range $45.00 – $61.00
Implied Upside
+2.9%
Consensus $51.25 vs current $49.81
NASDAQ·Healthcare·Biotechnology
$49.81
+0.60%
Mkt Cap $21.20B
Buy
4
Hold
0
Sell
0
Price Target (12 analysts)
$51.25
Range $45.00 – $61.00
+2.9%
Consensus $51.25 vs current $49.81